Company: HCTI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-109581
Chunk: 5

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
.3 
     (1,283) 
     - 
  
    Net cash used in investing activities 
      
     (1,289) 
     - 
  
    Cash flows from financing activities 

    Decrease in short term borrowing 
    3.9 
     (1,251) 
     (1,892)
  
    Interest paid 
      
     (467) 
     - 
  
    Net proceeds from equity issuance 
      
     14,305  
     956 
  
    Net cash provided by / (used in) financing activities 
      
     12,587  
     (936)

    Net changes in cash and cash equivalents 
      
     1,609  
     (1,206)
  
    Cash and cash equivalents 

    Cash and cash equivalents at the beginning of the period 
      
    $20  
    $1,234 
  
    Cash and cash equivalents at the end of the period 
      
    $1,629  
    $28 

    Non-cash investing and financing activities 

    Supplementary disclosure of cash flows information 

    Interest 
      
     -  
     360 
  
    Income taxes 
      
     -  
     8 
  
    Equity to be issued 
      
     3,000  
     - 
  
    Conversion of convertible note 
      
     -  
     1,181 
  
    Acquisition of assets 
      
     1,200  
     - 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

4

HEALTHCARE TRIANGLE, INC.

Notes To Condensed Consolidated Financial Statements

(Unaudited)

(In thousands except share and per share data)

1) Organization and Description of Business

Healthcare Triangle Inc. (“the
Company”) was incorporated under the laws of the State of Nevada on October 29, 2019, and then converted into a Delaware
corporation on April 24, 2020, to provide IT and data services to the Healthcare and Life Sciences (‘HCLS”) industry. On
January 1, 2020, the Company acquired the Life Sciences Business of SecureKloud Technologies Inc. (a related party)
(“Parent”) and on May 8, 202